THE EFFECT OF PREINCUBATION WITH CIMETIDINE ON THE N-HYDROXYLATION OF DAPSONE BY HUMAN LIVER-MICROSOMES

被引:22
|
作者
TINGLE, MD
COLEMAN, MD
PARK, BK
机构
[1] Department of Pharmacology and Therapeutics, Liverpool
基金
英国惠康基金;
关键词
DAPSONE; METABOLISM; CIMETIDINE; INHIBITION; METHEMOGLOBINEMIA;
D O I
10.1111/j.1365-2125.1991.tb05623.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have examined the ability of cimetidine to inhibit the oxidative metabolism and hence haemotoxicity of dapsone in vitro, using a two compartment system in which two Teflon(R) chambers are separated by a semi-permeable membrane. Compartment A contained a drug metabolizing system (microsomes prepared from human or rat liver +/- NADPH), whilst compartment B contained human red cells. Preincubation (30 min) of human liver microsomes with cimetidine (0-1000-mu-M) and NADPH prior to the addition of dapsone (100-mu-M) and NADPH (1 mM) resulted in a concentration-dependent decrease in the concentrations of dapsone hydroxylamine (from 179 +/- 47 to 40 +/- 6 ng) in compartment B. This reduction of hydroxylamine metabolite was reflected in the concentration-dependent reduction in methaemoglobin measured (from 7.1 +/- 0.7 to 3.5 +/- 1.5%) in parallel experiments. Preincubation of microsomes with cimetidine in the absence of NADPH had no effect. The effect of cimetidine pretreatment on dapsone-dependent methaemoglobin was confirmed using microsomes prepared from a further three sources of human liver, as well as from rat liver.
引用
收藏
页码:120 / 123
页数:4
相关论文
共 50 条
  • [42] METABOLISM OF DIAZEPAM IN HUMAN LIVER-MICROSOMES
    WANDEL, C
    BOCKER, R
    BROWNE, A
    BOHRER, H
    MARTIN, E
    ANESTHESIOLOGY, 1994, 81 (3A) : A394 - A394
  • [43] LAUDANOSINE BIOTRANSFORMATION IN HUMAN LIVER-MICROSOMES
    TABURET, AM
    SILVIE, M
    FURLAN, V
    SINGLAS, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 159 - 159
  • [44] REDUCTION OF AZT IN HUMAN LIVER-MICROSOMES
    CRETTON, EM
    PANZHOU, XR
    MAUREL, P
    SOMMADOSSI, JP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 138 - 138
  • [45] THE METABOLISM OF TRAMADOL BY HUMAN LIVER-MICROSOMES
    PAAR, WD
    FRANKUS, P
    DENGLER, HJ
    CLINICAL INVESTIGATOR, 1992, 70 (08): : 708 - 710
  • [46] AMIODARONE METABOLISM IN HUMAN LIVER-MICROSOMES
    HA, HR
    WYSS, PA
    STIEGER, B
    MEIER, PJ
    MEYER, UA
    FOLLATH, F
    FASEB JOURNAL, 1992, 6 (05): : A1845 - A1845
  • [47] INVITRO EFFECT OF FLUOROQUINOLONES ON THEOPHYLLINE METABOLISM IN HUMAN LIVER-MICROSOMES
    SARKAR, M
    POLK, RE
    GUZELIAN, PS
    HUNT, C
    KARNES, HT
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (04) : 594 - 599
  • [48] EFFECT OF PROGESTOGENS ON THE METABOLISM OF ETHYLOESTRADIOL BY HUMAN LIVER-MICROSOMES INVITRO
    BACK, DJ
    TJIA, JF
    HOULGRAVE, R
    ORME, ML
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (02) : P321 - P321
  • [49] N-HYDROXYLATION OF P-PHENETIDINE IN VIVO AND BY ISOLATED MICROSOMES OF LIVER AND KIDNEY - STIMULATION BY PHENOBARBITAL-PRETREATMENT
    UEHLEKE, H
    NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1969, 264 (04): : 434 - &
  • [50] DRUG HYDROXYLATION AND GLUCURONIDATION IN LIVER-MICROSOMES OF PHENOBARBITAL-TREATED RATS
    VAINIO, H
    XENOBIOTICA, 1973, 3 (11) : 715 - 725